share_log

Morgan Stanley Maintains Equal-Weight on Third Harmonic Bio, Raises Price Target to $7

Benzinga ·  Aug 11, 2023 09:16

Morgan Stanley analyst Michael Ulz maintains Third Harmonic Bio (NASDAQ:THRD) with a Equal-Weight and raises the price target from $5 to $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment